Morgan Stanley Explains Why Clorox (CLX) Pain Isn't Over, PT Lowered to $160 at
Tweet Send to a Friend
Morgan Stanley analyst Dara Mohsenian lowered the price target on Clorox (NYSE: CLX) to $160.00 (from $170.00) after a big ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
